Text Size:
Color Theme:

Company Information

Five-year assets, liabilities and shareholders’ funds.

Balance Sheet

BIOPOL CHEMICALS LTD.

NSE Code
BIOPOLSM
BSE Code
-
ISIN
INE0XW001014
Industry
Chemicals - Speciality
Financial Data

Balance Sheet

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Table can be scrolled horizontally on smaller screens.

Five-year standalone Balance Sheet for the selected company
ParticularsMar 26Mar 25Mar 24Mar 23
Months12121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARAR
FaceValue10.0010.0010.0010.00
No. of Equity Shares (in Lacs)108.0579.1179.110.00
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital10.817.917.911.79
Total Share Capital10.817.917.911.79
Reserves and Surplus39.125.621.290.00
Total Reserves and Surplus39.125.621.290.00
Total Shareholders Funds49.9213.539.201.79
NON-CURRENT LIABILITIES
Long Term Borrowings5.060.630.004.50
Long Term Provisions0.070.060.050.04
Total Non-Current Liabilities5.120.690.054.54
CURRENT LIABILITIES
Short Term Borrowings3.417.063.582.19
Trade Payables6.448.543.842.87
Other Current Liabilities0.490.360.591.01
Short Term Provisions4.401.300.300.03
Total Current Liabilities14.7317.258.316.10
Total Capital And Liabilities69.7831.4817.5612.43
ASSETS
NON-CURRENT ASSETS
Tangible Assets14.240.220.210.27
Capital Work-In-Progress0.120.000.060.00
Fixed Assets14.360.230.270.27
Non-Current Investments0.000.000.000.79
Deferred Tax Assets [Net]0.040.040.030.02
Long Term Loans And Advances0.360.000.000.42
Other Non-Current Assets0.000.010.000.26
Total Non-Current Assets14.760.270.301.76
CURRENT ASSETS
Inventories19.6111.816.131.60
Trade Receivables27.7916.6610.137.01
Cash And Cash Equivalents0.521.150.080.06
Short Term Loans And Advances4.831.580.912.00
OtherCurrentAssets2.280.000.000.00
Total Current Assets55.0231.2017.2610.67
Total Assets69.7831.4817.5612.43
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities0.000.000.003.02
BONUS DETAILS
Bonus Equity Share Capital0.007.807.800.00

Source: Financial statements as reported by the company.